Who are analogous Lingdancao granules's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Yangxinshi tablet simulants, Standard treatment+Xiyanping injection, Sanjin tablets simulants, Naoxintong Capsule, Erigeron breviscapus injection, Naoan dripping pills.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/analogous-lingdancao-granules.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

analogous Lingdancao granules — Competitive Intelligence Brief

analogous Lingdancao granules (analogous Lingdancao granules) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine. Area: Immunology.

phase 3 Traditional Chinese medicine Immunology Small molecule Live · refreshed every 30 min

Target snapshot

analogous Lingdancao granules (analogous Lingdancao granules) — The First Affiliated Hospital of Guangzhou Medical University. Lingdancao granules, analogous to traditional Chinese medicine, are believed to modulate the immune system and exhibit anti-inflammatory properties.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
analogous Lingdancao granules TARGET	analogous Lingdancao granules	The First Affiliated Hospital of Guangzhou Medical University	phase 3	Traditional Chinese medicine
Yangxinshi tablet simulants	Yangxinshi tablet simulants	Dongzhimen Hospital, Beijing	marketed	Traditional Chinese medicine herbal formulation
Standard treatment+Xiyanping injection	Standard treatment+Xiyanping injection	Jiangxi Qingfeng Pharmaceutical Co. Ltd.	marketed	Traditional Chinese medicine extract
Sanjin tablets simulants	Sanjin tablets simulants	China Academy of Chinese Medical Sciences	marketed	Traditional Chinese medicine
Naoxintong Capsule	Naoxintong Capsule	Chinese Academy of Medical Sciences, Fuwai Hospital	marketed	Traditional Chinese Medicine (herbal formulation)
Erigeron breviscapus injection	Erigeron breviscapus injection	Guangzhou University of Traditional Chinese Medicine	marketed	Traditional Chinese medicine extract; antiplatelet/microcirculation enhancer
Naoan dripping pills	Naoan dripping pills	Dongzhimen Hospital, Beijing	marketed	Traditional Chinese medicine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine class)

Shanghai University of Traditional Chinese Medicine · 2 drugs in this class
Jiangsu Famous Medical Technology Co., Ltd. · 2 drugs in this class
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · 1 drug in this class
Sichuan Jishengtang Pharmaceutical Co., Ltd. · 1 drug in this class
Tasly Pharmaceutical Group Co., Ltd · 1 drug in this class
China Academy of Chinese Medical Sciences · 1 drug in this class
The First Affiliated Hospital of Guangzhou Medical University · 1 drug in this class
Dongzhimen Hospital, Beijing · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). analogous Lingdancao granules — Competitive Intelligence Brief. https://druglandscape.com/ci/analogous-lingdancao-granules. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab